131 related articles for article (PubMed ID: 22566771)
1. Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
Röhricht F; Gadhia S; Alam R; Willis M
ScientificWorldJournal; 2012; 2012():512047. PubMed ID: 22566771
[TBL] [Abstract][Full Text] [Related]
2. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
Bobo WV; Jayathilake K; Lee MA; Meltzer HY
Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Sumiyoshi T; Jayathilake K; Meltzer HY
Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
[TBL] [Abstract][Full Text] [Related]
4. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Sumiyoshi T; Jayathilake K; Meltzer HY
Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636
[TBL] [Abstract][Full Text] [Related]
5. Melperone in the treatment of neuroleptic-resistant schizophrenia.
Meltzer HY; Sumiyoshi T; Jayathilake K
Psychiatry Res; 2001 Dec; 105(3):201-9. PubMed ID: 11814539
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
[TBL] [Abstract][Full Text] [Related]
8. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Bobo WV; Jayathilake K; Lee MA; Meltzer HY
Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
11. A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.
Härnryd C; Bjerkenstedt L; Gullberg B
Acta Psychiatr Scand Suppl; 1989; 352():40-7. PubMed ID: 2573240
[TBL] [Abstract][Full Text] [Related]
12. Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs.
Meltzer HY; Koenig JI; Nash JF; Gudelsky GA
Acta Psychiatr Scand Suppl; 1989; 352():24-9. PubMed ID: 2573238
[TBL] [Abstract][Full Text] [Related]
13. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
15. Melperone in treatment-refractory schizophrenia: a case series.
Whiskey E; Vavrova M; Gaughran F; Taylor D
Ther Adv Psychopharmacol; 2011 Feb; 1(1):19-23. PubMed ID: 23983923
[TBL] [Abstract][Full Text] [Related]
16. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological data of the atypical neuroleptic compound melperone (Buronil).
Christensson EG
Acta Psychiatr Scand Suppl; 1989; 352():7-15. PubMed ID: 2573242
[TBL] [Abstract][Full Text] [Related]
18. The mode of antiarrhythmic action of melperone.
Platou ES; Refsum H; Myhre ES; Amlie JP; Landmark K
Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):108-12. PubMed ID: 6122332
[TBL] [Abstract][Full Text] [Related]
19. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
Kirkegaard A; Kirkegaard G; Geismar L; Christensen I
Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835
[TBL] [Abstract][Full Text] [Related]
20. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
Barbato L; Monge A; Stocchi F; Nordera G
Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
